SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 26th, 2023 • Vaccinex, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September [●], 2023, between Vaccinex, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Vaccinex, Inc. Attention: Mr. Maurice Zauderer, Ph.D.Vaccinex, Inc. • September 26th, 2023 • Pharmaceutical preparations • New York
FORM OF COMMON STOCK PURCHASE WARRANT VACCINEX, INC.Vaccinex, Inc. • September 26th, 2023 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [ ], 20[ ] (the “Termination Date”), but not thereafter, to subscribe for and purchase from Vaccinex, Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
